Skip to main content
Equibles

DIMENSIONAL FUND ADVISORS LP

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 354204 AUSTIN, TX
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$925,339
-$458,542 QoQ
Shares Held
115,523
-33.0% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 208 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. SPRY ranks #162 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,168,956 $580,655,511
2 JAZZ
Jazz Pharmaceuticals plc
 1,713,592 $412,924,262
3 REGN
Regeneron Pharmaceuticals, Inc.
 559,687 $348,987,230
4 INCY
Incyte Corp
 2,280,803 $258,551,825
5 EXEL
Exelixis, Inc.
 4,426,620 $240,852,392
6 BMRN
Biomarin Pharmaceutical Inc
 4,075,714 $233,212,353
7 ROIV
Roivant Sciences Ltd.
 5,230,417 $185,104,455
8 KRYS
Krystal Biotech, Inc.
 476,038 $176,929,041

All Filings in SPRY

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $925,339 115,523
2026-03-31 $1,383,881 172,339
2025-12-31 $2,051,820 176,122
2025-09-30 $1,790,387 178,148
2025-06-30 $3,149,584 180,492
2025-03-31 $2,360,572 187,645
2024-12-31 $2,072,631 196,458
2024-09-30 $2,790,495 192,448
2024-06-30 $1,637,730 192,448
2024-03-31 $2,813,453 275,289
2023-12-31 $1,779,497 324,726
2023-09-30 $1,412,728 373,738
2023-06-30 $2,637,454 393,650
2023-03-31 $2,176,024 334,259
2022-12-31 $2,849,811 334,093
2022-09-30 $1,746,275 330,734
2022-06-30 $271,873 64,121